Induction of CYP1A by various benzimidazoles and its significance in administrative drug regulation.
Kleeberg
U
U
Federal Institute of Drugs and Medical Devices (BfArM), Berlin, Germany. u.kleeberg@bfarm.de
Frötschl
R
R
Krusekopf
S
S
Brockmöller
J
J
Roots
I
I
Ruckpaul
K
K
Hildebrandt
A G
AG
D001562:Benzimidazoles / Q000494:pharmacology*; D019363:Cytochrome P-450 CYP1A1 / Q000096:biosynthesis*; D004347:Drug Interactions; D004335:Drug and Narcotic Control; D004790:Enzyme Induction; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology; D014158:Transcription, Genetic / Q000187:drug effects
D001562:Benzimidazoles; D004791:Enzyme Inhibitors; D019363:Cytochrome P-450 CYP1A1